1. Home
  2. VLOS vs AVIR Comparison

VLOS vs AVIR Comparison

Compare VLOS & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VLOS

Velos Acquisition I Corp. Class A Ordinary shares

N/A

Current Price

$10.72

Market Cap

388.1M

Sector

N/A

ML Signal

N/A

Logo Atea Pharmaceuticals Inc.

AVIR

Atea Pharmaceuticals Inc.

N/A

Current Price

$5.10

Market Cap

429.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VLOS
AVIR
Founded
2024
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
388.1M
429.1M
IPO Year
2024
2020

Fundamental Metrics

Financial Performance
Metric
VLOS
AVIR
Price
$10.72
$5.10
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $9.42
AVG Volume (30 Days)
60.2K
★ 245.7K
Earning Date
08-13-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 3.00
EPS
★ N/A
N/A
Revenue
N/A
★ $351,367,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.55
$2.81
52 Week High
$10.90
$6.45

Technical Indicators

Market Signals
Indicator
VLOS
AVIR
Relative Strength Index (RSI) 48.40 46.26
Support Level N/A $5.01
Resistance Level $10.73 $5.76
Average True Range (ATR) 0.03 0.19
MACD -0.00 -0.03
Stochastic Oscillator 52.94 25.19

Price Performance

Historical Comparison
VLOS
AVIR

About VLOS Velos Acquisition I Corp. Class A Ordinary shares

Velos Acquisition I Corp, formerly M3-Brigade Acquisition V Corp, is a blank check company.

About AVIR Atea Pharmaceuticals Inc.

Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.

Share on Social Networks: